TALWIN 50 bulk active fine chemical sources

Subscribe to access the full database, or Start Trial
Vendor	Vendor Homepage	Vendor Sku	API Url
J&H Chemical Co.,ltd	⤷ Start Trial	JH216001	⤷ Start Trial
RR Scientific	⤷ Start Trial	R6074978	⤷ Start Trial
EvitaChem	⤷ Start Trial	evt-1548825	⤷ Start Trial
>Vendor	>Vendor Homepage	>Vendor Sku	>API Url

Last updated: August 9, 2025

Introduction

TALWIN 50, a combination medication primarily used for pain management and opioid dependence therapy, contains pentazocine—an opioid agonist-antagonist. As a crucial component, pentazocine's quality, availability, and sourcing critically influence the safety, efficacy, and regulatory compliance of the final pharmaceutical product. This article explores the global landscape for bulk API procurement for TALWIN 50, highlighting key suppliers, sourcing considerations, regulatory compliance, and market dynamics.

Overview of Pentazocine API in TALWIN 50

TALWIN 50 typically comprises 50 mg of pentazocine per tablet, combined with other excipients. The drug's manufacturing depends heavily on sourcing high-purity pentazocine API, which must adhere to stringent pharmacopoeial standards (USP, EP, or JP). Given the opioid nature, sourcing also involves navigating regulatory landscapes related to controlled substances, which affects the selection of suppliers and distribution channels.

Global API Manufacturers of Pentazocine

The production of pentazocine API is limited to a select group of pharmaceutical API manufacturers, predominantly located in Asia, Europe, and North America. These producers supply bulk pentazocine to pharmaceutical companies worldwide, either as branded or generic APIs.

1. Domestic and Regional Suppliers

India: India remains a prominent hub for generic APIs, including pentazocine, owing to its robust chemical manufacturing infrastructure. Companies such as Sun Pharmaceutical Industries and Lupin reportedly produce pentazocine API, adhering to cGMP standards, and supply to both domestic and international markets.
China: Chinese API manufacturers have ramped up production capabilities and are significant suppliers of generic APIs. Firms like Qingdao Seazen Pharma and Wuhan Hissen Chemical Industry are known to produce pentazocine API, although detailed disclosures are limited due to confidentiality agreements.
Eastern Europe: Some European API producers, such as Harlan Laboratories (now part of Eurofins), have historically supplied pentazocine, often for clinical trials or limited commercial use, but their involvement in large-scale production varies.

2. International API Manufacturers

Mid-Size and Specialty Firms: Several mid-sized API manufacturers in South Korea, Turkey, and Brazil focus on niche opioids, including pentazocine, meeting regulatory standards for global distribution.
Major Pharma-CDMO (Contract Development and Manufacturing Organizations): Companies like Bachem and Thermo Fisher Scientific sometimes offer custom synthesis services for opioids; although they primarily focus on research and development, some have the capacity for GMP-grade bulk APIs.

Key Factors in API Sourcing for TALWIN 50

Regulatory Compliance and Control

Due to pentazocine's classification as an controlled substance (Schedule IV in the US, Schedule 4 in other jurisdictions), sourcing must align with strict regulatory frameworks. Suppliers must possess appropriate licenses, and documentation regarding manufacturing practices, security measures, and tracking systems are essential.

Quality and Purity Standards

Manufacturers must ensure the API complies with pharmacopeial standards (USP, EP, JP). Certificates of Analysis (CoA), stability data, and batch records are necessary for regulatory submissions and quality assurance.

Supply Chain Security

Given the opioid regulatory environment, supply chain integrity is paramount. Disruptions due to geopolitical issues, export controls, or manufacturing outages can impact API availability.

Pricing and Contract Terms

Cost competitiveness, lead times, minimum order quantities, and willingness to engage in long-term supply agreements influence sourcing decisions.

Market Dynamics and Challenges

Regulatory Barriers

Strict regulations around opioids restrict API manufacture, transport, and sale. Several authorities require careful recordkeeping, security measures, and periodic audits, limiting the number of qualified suppliers.

Supply Chain Disruptions

The COVID-19 pandemic underscored vulnerabilities in global pharmaceutical supply chains, including API shortages and delays. Geopolitical tensions, such as US-China trade relations, further complicate sourcing.

Emerging Trends

API Synthesis Innovation: Companies are exploring alternative synthesis routes to improve yields, reduce costs, and enhance safety.
API Quality Upgrades: Increasing emphasis on Good Manufacturing Practice (GMP) compliance and environmental standards.

Key Considerations for Pharmaceutical Companies

Vendor Vetting: Prioritize API suppliers with proven GMP compliance, robust security, and comprehensive regulatory documentation.
Regulatory Due Diligence: Ensure suppliers possess necessary licenses and are compliant with local and international regulations.
Supply Chain Resilience: Diversify sourcing channels, considering multiple suppliers and geographic regions.
Cost Negotiation: Balance cost efficiency with quality and regulatory compliance, especially in controlled substance markets.
Long-term Partnerships: Establish strategic alliances with reliable API producers for sustained supply and regulatory support.

Conclusion

The sourcing landscape for pentazocine API—integral to TALWIN 50—continues to evolve amid regulatory pressures, quality demands, and geopolitical factors. Major producers in India, China, and select regions dominate the market, offering manufacturers multiple sourcing options. However, due diligence, regulatory adherence, and supply chain resilience remain critical for securing high-quality APIs consistently.

Key Takeaways

Sourcing pentazocine API involves navigating complex regulatory environments due to its classification as an opioid.
India and China are primary manufacturing hubs with reputable suppliers, but regional factors and compliance standards influence their suitability.
Ensuring API quality, security, and regulatory licensing are fundamental to successful procurement.
Diversifying suppliers and maintaining strong regulatory oversight mitigate risks of shortages or compliance violations.
Advances in API synthesis and quality standards favor long-term strategic sourcing collaborations.

FAQs

1. What are the primary regulatory concerns when sourcing pentazocine API?
Manufacturers must comply with controlled substance regulations, including licensing, security protocols, and documentation requirements, to legally produce and distribute pentazocine API globally.

2. Which countries dominate the production of pentazocine API?
India and China are the leading producers due to their extensive chemical manufacturing infrastructure, with additional suppliers emerging from regions like Eastern Europe and Asia-Pacific.

3. How does API quality impact TALWIN 50 manufacturing?
High-quality API ensures product efficacy, safety, and regulatory approval. Substandard or impure API can lead to recalls, regulatory sanctions, and compromised patient safety.

4. Are there concerns about API supply shortages for opioids like pentazocine?
Yes. Supply chain disruptions, regulatory tightening, and geopolitical issues can cause shortages, emphasizing the need for diversified sourcing and strategic inventory management.

5. What strategies can pharmaceutical companies employ for reliable API sourcing?
Companies should conduct thorough vendor assessments, prioritize GMP compliance, maintain multiple supplier relationships, and stay abreast of regulatory changes to ensure a resilient supply chain.

Sources:

[1] U.S. Pharmacopeia, "Pentazocine Hydrochloride," USP Monograph, 2022.
[2] European Pharmacopoeia, "Pentazocine," 11th Edition.
[3] IMS Health Data, "Global API Manufacturing Market," 2022.
[4] Pharmaceutical Technology, "Opioid API Regulation and Supply Chain Challenges," 2021.
[5] Industry Reports on Opioid API Manufacturers, 2022.

Bulk Pharmaceutical API Sources for TALWIN 50